Log in to search using one of your social media accounts:

University of Utah v. Max-Planck; United States Court of Appeals of the Federal Circuit, 2017; 851 F.3d 1317
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 143-146. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Novartis AG v. Noven Pharm. Inc.; United States Court of Appeals of the Federal Circuit, 2017; 853 F.3d 1289
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 139-141. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Mussa Ali v. Carnegie Institution of Washington; United States Court of Appeals of the Federal Circuit, 2017; 2017 WL 1349280 (Federal Reporter citation currently unavailable)
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 135-138. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Medicines Co. v. Mylan, Inc.; United States Court of Appeals of the Federal Circuit, 2017; 853 F.3d 1296
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 127-133. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Helsinn Healthcare S.A. v. Teva Pharm. USA, Inc.; United States Court of Appeals of the Federal Circuit, 2017; 2017 WL 1541518 (Federal Reporter citation currently unavailable)
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 121-126. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Bayer CropScience AG v. Dow AgroSciences LLC; United States Court of Appeals of the Federal Circuit, 2017; 851 F.3d 1302
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 117-120. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Patent Law and the Emerging Science of Synthetic Biology: An Examination of Principle and Practice Part 2
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 105-116. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Trade Secret Protection on Technical Information in a Premarket Notification Submission for a Medical Device After TaiDoc Tech. Corp. v. OK Biotech Co.
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 93-104. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Global Supply Chains for Life Sciences: Develop and Maintain a Tax-Efficient International Structure
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 85-91. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

A Biotechnology-Centric Look at Fee Shifting in Patent Litigation Post-Octane Fitness
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 81-84. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 79-80. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Biosimilar Companies Chipping Away at Humira, but No Death Knells Yet
Biotechnology Law Report Jun 2017, Vol. 36, No. 3: 75-77. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 1, 2017 Category: Medical Law Source Type: research

Patent Law and the Emerging Science of Synthetic Biology: An Examination of Principle and Practice
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 59-74. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

Can Diagnostic Data Be Protected as a “Direct Product” of a Process?
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 53-57. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

In Life Technologies v. Promega the Supreme Court Leaves Unresolved Many Questions Regarding the Potential for Infringement Under 35 U.S.C. § 271(f)(1)
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 43-51. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

The Legal Battle Around CRISPR Gene-Editing Technology and Its Implications
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 39-42. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

Eli Lilly v. Teva: Generic Companies Infringe Under Akamai IV in Case of Divided Infringement
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 31-37. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 27-29. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

Senate Committee Holds Confirmation Hearing for Nominee for New FDA Commissioner
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 25-26. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 1, 2017 Category: Medical Law Source Type: research

A Medical Diagnosis Is Not an Immediate Product of a Process in the Meaning of § 9, Sentence 2, No. 3 PatG
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 23-23. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

New Guidances from FDA for Biosimilars and Interchangeables
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 17-21. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

AbbVie Hopes to Maintain Humira Exclusivity Through Secondary Patents and Regulatory Barriers to Entry
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 9-16. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 5-7. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

The 2017 Update to the Coordinated Framework for the Regulation of Biotechnology
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 1-3. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

Biotechnology Patenting in Small Countries —Strategies for the International Marketplace
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 291-299. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Mindaugas Kiskis Tadas Limba Source Type: research

The Status Quo and Development Strategies for Patent Pledge Financing in the Biopharmaceutical Industry in China
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 285-290. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Yunhua Liu Jing Li Source Type: research

Considerations Regarding Patent Assertion Entities in the Biotechnology Field: New FTC Study Released
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 281-284. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Ricardo Unikel Source Type: research

The Biotechnology Regulatory Authority of India Bill, 2013 —A Threat to the Safety of India's Food and Farming
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 269-280. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: A. Saravanan Source Type: research

A Decade of Data Protection for Innovative Drugs in Canada: Issues, Limitations, and Time for a Reassessment
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 259-267. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Megan Kendall Declan Hamill Source Type: research

Setbacks in Implementing the Renewable Fuel Standard Lead to Calls for Reform
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 249-257. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 247-248. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Post-Election Uncertainty and Opportunity Beckon
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 245-246. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Lucian C. Chen Source Type: research

After Two Years, Alice Is Still Stifling Life Sciences Patents; But the Tide May Be Shifting at the Federal Circuit
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 239-244. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Lucian C. Chen Source Type: research

The Status of Patent Eligibility in the Area of Biotechnology: Practical Considerations for Patent Prosecutors
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 225-238. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Mike Sanzo Source Type: research

Biophysical Evidence Relevant to the Patentability of Engineered Antibodies: Using Computational Simulations to Assist the Objective Analysis Required by Section § 112(a)
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 187-223. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Brian K. Lathrop Source Type: research

Mayo Update: Some Reason for Guarded Optimism
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 175-185. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 171-173. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Turbulent and Exciting Times at BLR
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 169-169. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Lucian C. Chen Source Type: research

Patenting Genes in China, the U.S., and the EU: How Does It Differ? Could It Get Out of Control?
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 165-168. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Wei Li Source Type: research

Patenting Decisions by South African Biotechnology Entrepreneurs
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 147-163. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Donrich W. Jordaan Source Type: research

Succession in Title and Priority Entitlement in the European Patent Office
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 141-146. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Steven M. Zeman Source Type: research

The Medicines Company v. Hospira: When Does Outsourcing Drug Manufacture to a Third-Party Contractor Trigger an On-Sale Bar to Patentability?
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 129-136. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 125-127. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Controversy and Guidance for Biosimilar Labeling
Biotechnology Law Report , Vol. 0, No. 0. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 22, 2016 Category: Medical Law Authors: Vishal GuptaRichard Praseuth Source Type: research

Supplementary Document 2: Affirmance of Refusal for Registration
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 119-124. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Source Type: research

Supplementary Document 1: Request for Reconsideration of Denial of Copyright Registration of Prancer DNA Sequence
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 113-118. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Source Type: research

Are Engineered Genetic Sequences Copyrightable?: The U.S. Copyright Office Addresses a Matter of First Impression
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 103-111. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Christopher M. HolmanClaes GustafssonAndrew W. Torrance Source Type: research

Independent Consultant on Intellectual Property
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 99-102. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Richard J. WarburgRobert Kelly MooreStephen B. Maebius Source Type: research

Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 93-97. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Yu JiFeixiang Guo Source Type: research

Genetic Technologies Ltd. v. Merial L.L.C.: Gene-Based Assays in the Wake of Mayo
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 89-92. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Michael Sanzo Source Type: research